{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:48:08Z","timestamp":1791244088834,"version":"4.1.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tmreviews.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.tmrv.2016.08.004","type":"journal-article","created":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T23:21:12Z","timestamp":1475796072000},"page":"26-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond"],"prefix":"10.1016","volume":"31","author":[{"given":"Carlos H.","family":"Villa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Cines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don L.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Muzykantov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2016.08.004_bb0005","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/17425247.2015.1086745","article-title":"Intracellular delivery of nanocarriers and targeting to subcellular organelles","volume":"13","author":"Jhaveri","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.addr.2015.02.005","article-title":"The neonatal fc receptor, FcRn, as a target for drug delivery and therapy","volume":"91","author":"Sockolosky","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2016.02.007","article-title":"Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems","author":"Villa","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0025","doi-asserted-by":"crossref","first-page":"291ra294","DOI":"10.1126\/scitranslmed.aaa5447","article-title":"Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells","volume":"7","author":"Huang","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0030","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1182\/blood-2014-07-587139","article-title":"Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models","volume":"125","author":"Pickens","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0035","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4155\/tde.15.34","article-title":"Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier","volume":"6","author":"Villa","year":"2015","journal-title":"Ther Deliv"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0040","series-title":"Erythrocytes as drug carriers in medicine","author":"Sprandel","year":"2013"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0045","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2012-05-427856","article-title":"Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation","volume":"120","author":"Whelihan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2249.2011.04459.x","article-title":"Dual role of erythrocyte complement receptor type 1 in immune complex-mediated macrophage stimulation: implications for the pathogenesis of Plasmodium falciparum malaria","volume":"166","author":"Odera","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0055","first-page":"4613","article-title":"A study of in vivo immune complex formation and clearance in man","volume":"144","author":"Davies","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0060","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1172\/JCI115619","article-title":"Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions","volume":"89","author":"Coller","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0065","first-page":"5088","article-title":"Escherichia coli bound to the primate erythrocyte complement receptor via bispecific monoclonal antibodies are transferred to and phagocytosed by human monocytes in an in vitro model","volume":"160","author":"Kuhn","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.imlet.2004.07.007","article-title":"Staphylococcus aureus bound to complement receptor 1 on human erythrocytes by bispecific monoclonal antibodies is phagocytosed by acceptor macrophages","volume":"95","author":"Gyimesi","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0075","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4049\/jimmunol.166.2.1057","article-title":"Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia","volume":"166","author":"Hahn","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.molimm.2013.09.005","article-title":"Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor","volume":"57","author":"Sharma","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/abio.1994.1559","article-title":"Attachment of biotinylated antibody to red blood cells: antigen-binding capacity of immunoerythrocytes and their susceptibility to lysis by complement","volume":"223","author":"Muzykantov","year":"1994","journal-title":"Anal Biochem"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/art.1780380207","article-title":"Antigen-based heteropolymers. A potential therapy for binding and clearing autoantibodies via erythrocyte CR1","volume":"38","author":"Ferguson","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0095","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jconrel.2014.03.038","article-title":"Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes","volume":"183","author":"Mukthavaram","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0100","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1021\/nn404853z","article-title":"Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells","volume":"7","author":"Anselmo","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.7541557","article-title":"In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium","volume":"269","author":"Kooyman","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0110","doi-asserted-by":"crossref","first-page":"11420","DOI":"10.1039\/C5NR01355K","article-title":"Influence of the glycocalyx and plasma membrane composition on amphiphilic gold nanoparticle association with erythrocytes","volume":"7","author":"Atukorale","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1073\/pnas.76.1.473","article-title":"Incorporation of glucocerebrosidase into Gaucher's disease monocytes in vitro","volume":"76","author":"Dale","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1517\/14712598.2012.650163","article-title":"Erythrocytes as carriers for drugs: the transition from the laboratory to the clinic is approaching","volume":"12","author":"Magnani","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2006.06.032","article-title":"Applications of carrier erythrocytes in delivery of biopharmaceuticals","volume":"118","author":"Hamidi","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/17425247.2.2.311","article-title":"Erythrocyte-based drug delivery","volume":"2","author":"Rossi","year":"2005","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0135","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1073\/pnas.70.9.2663","article-title":"Enzyme loading of erythrocytes","volume":"70","author":"Ihler","year":"1973","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0140","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2141.2000.02059.x","article-title":"In vitro and in vivo studies with human carrier erythrocytes loaded with polyethylene glycol-conjugated and native adenosine deaminase","volume":"109","author":"Bax","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0145","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/47.6.819","article-title":"Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus","volume":"47","author":"Rossi","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0150","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/j.vaccine.2010.02.013","article-title":"In situ targeting of dendritic cells by antigen-loaded red blood cells: a novel approach to cancer immunotherapy","volume":"28","author":"Banz","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0155","first-page":"188","article-title":"Red blood cells as an antigen-delivery system","volume":"16","author":"Magnani","year":"1992","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0160","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1111\/j.1572-0241.2008.02103.x","article-title":"Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study","volume":"103","author":"Bossa","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/BA20000087","article-title":"Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease","volume":"33","author":"Rossi","year":"2001","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1358\/dof.2012.037.04.1779020","article-title":"Enzyme bioreactors as drugs","volume":"37","author":"Godfrin","year":"2012","journal-title":"Drugs Future"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2141.2011.08588.x","article-title":"L-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial","volume":"153","author":"Domenech","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0180","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1517\/14712598.2012.631909","article-title":"International seminar on the red blood cells as vehicles for drugs","volume":"12","author":"Godfrin","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0185","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-0609.2007.00927.x","article-title":"A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency","volume":"79","author":"Bax","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0190","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.addr.2007.08.029","article-title":"Cell-based drug delivery","volume":"60","author":"Pierige","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0195","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1212\/WNL.0b013e3182a6cb4b","article-title":"Clinical and biochemical improvements in a patient with MNGIE following enzyme replacement","volume":"81","author":"Bax","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0200","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/bcmd.1997.0119","article-title":"Red cell-mediated therapy: opportunities and challenges","volume":"23","author":"Krantz","year":"1997","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0205","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/138161208783330772","article-title":"Drug loaded erythrocytes: as novel drug delivery system","volume":"14","author":"Patel","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0210","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.jconrel.2006.09.041","article-title":"Erythrocytes as a controlled drug delivery system: clinical evidences","volume":"116","author":"Rossi","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-4347(95)00433-5","article-title":"Heterogeneity of hypotonically loaded rat erythrocyte populations as detected by counter-current distribution in aqueous polymer two-phase systems","volume":"677","author":"P\u00e9rez","year":"1996","journal-title":"J Chromatogr B Biomed Appl"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0220","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/oxfordjournals.jbchem.a021411","article-title":"In vivo survival and organ uptake of loaded carrier rat erythrocytes","volume":"120","author":"Alvarez","year":"1996","journal-title":"J Biochem"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0225","first-page":"175","article-title":"Immunological response to l-asparaginase loaded into red blood cells","volume":"326","author":"Ktavtzoff","year":"1992","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0230","first-page":"621","article-title":"Construction and characterization of adriamycin-loaded canine red blood cells as a potential slow delivery system","volume":"12","author":"Tonetti","year":"1990","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0235","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1073\/pnas.84.19.6894","article-title":"Long-term physiological effects of enhanced O2 release by inositol hexaphosphate-loaded erythrocytes","volume":"84","author":"Teisseire","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0240","first-page":"1521","article-title":"Comparison of modified technetium-99m albumin and technetium-99m red blood cells for equilibrium ventriculography","volume":"38","author":"Hambye","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s002280050187","article-title":"Tolerance evaluation of l-asparaginase loaded in red blood cells","volume":"51","author":"Kravtzoff","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0250","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF00195932","article-title":"Improved pharmacodynamics of l-asparaginase-loaded in human red blood cells","volume":"49","author":"Kravtzoff","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0255","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-9-5","article-title":"Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trial","volume":"9","author":"Chessa","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0260","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0005-2736(95)00260-X","article-title":"Target-sensitive immunoerythrocytes: interaction of biotinylated red blood cells with immobilized avidin induces their lysis by complement","volume":"1279","author":"Muzykantov","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0265","first-page":"189","article-title":"Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation","volume":"326","author":"Magnani","year":"1992","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0270","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0003-2697(87)90450-7","article-title":"Selective labeling of sulfhydryls and disulfides on blot transfers using avidin-biotin technology: studies on purified proteins and erythrocyte membranes","volume":"161","author":"Bayer","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0275","first-page":"276","article-title":"Directed targeting of immunoerythrocytes provides local protection of endothelial cells from damage by hydrogen peroxide","volume":"128","author":"Muzykantov","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0280","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0006-291X(86)80577-0","article-title":"P-Diazobenzoyl biocytin\u2014a new biotinylating reagent for the labeling of tyrosines and histidines in proteins","volume":"138","author":"Wilchek","year":"1986","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0285","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/adhm.201300084","article-title":"Distearoyl anchor-painted erythrocytes with prolonged ligand retention and circulation properties in vivo","volume":"3","author":"Shi","year":"2014","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0290","first-page":"171","article-title":"In vitro targeting of erythrocytes to cytotoxic T-cells by coupling of Thy-1.2 monoclonal antibody","volume":"15","author":"Chiarantini","year":"1992","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0295","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1073\/pnas.83.17.6603","article-title":"Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall","volume":"83","author":"Smirnov","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 2","key":"10.1016\/j.tmrv.2016.08.004_bb0300","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/bj2730393","article-title":"Avidin acylation prevents the complement-dependent lysis of avidin-carrying erythrocytes","volume":"273","author":"Muzykantov","year":"1991","journal-title":"Biochem J"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0305","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/039139889201501010","article-title":"Fast lysis by complement and uptake by liver of avidin-carrying biotinylated erythrocytes","volume":"15","author":"Muzykantov","year":"1992","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0310","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0014-5793(91)80216-P","article-title":"Streptavidin-induced lysis of homologous biotinylated erythrocytes. Evidence against the key role of the avidin charge in complement activation via the alternative pathway","volume":"280","author":"Muzykantov","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0315","first-page":"41","article-title":"Attachment of antibody to biotinylated red blood cells: immuno-red blood cells display high affinity to immobilized antigen and normal biodistribution in rats","volume":"24","author":"Muzykantov","year":"1996","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0320","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0022-1759(93)90212-P","article-title":"Avidin attachment to red blood cells via a phospholipid derivative of biotin provides complement-resistant immunoerythrocytes","volume":"158","author":"Muzykantov","year":"1993","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0325","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-5793(00)01204-7","article-title":"Preparation and characterization of \u2018heparinocytes\u2019: erythrocytes with covalently bound low molecular weight heparin","volume":"468","author":"M\u00fcller","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0330","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-4165(86)90184-4","article-title":"Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clot","volume":"884","author":"Muzykantov","year":"1986","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0335","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/jpet.104.075770","article-title":"Blood clearance and activity of erythrocyte-coupled fibrinolytics","volume":"312","author":"Ganguly","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0340","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2009.07.003","article-title":"Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile","volume":"139","author":"Murciano","year":"2009","journal-title":"J Control Release"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0345","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nbt846","article-title":"Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes","volume":"21","author":"Murciano","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0350","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/voxs.12197","article-title":"The emerging role for red blood cells in haemostasis: opportunity for intervention","volume":"11","author":"Villa","year":"2016","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0355","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1089\/neu.2008.0666","article-title":"Urokinase plasminogen activator impairs SNP and PGE2 cerebrovasodilation after brain injury through activation of LRP and ERK MAPK","volume":"25","author":"Armstead","year":"2008","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0360","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1161\/01.STR.0000181078.74698.b0","article-title":"Plasminogen activators contribute to impairment of hypercapnic and hypotensive cerebrovasodilation after cerebral hypoxia\/ischemia in the newborn pig","volume":"36","author":"Armstead","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0365","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1097\/PCC.0b013e3181fe40a7","volume":"12","author":"Armstead","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0370","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/CIRCULATIONAHA.107.750257","article-title":"Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator","volume":"118","author":"Danielyan","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0375","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/jcbfm.2009.61","article-title":"Red blood cells-coupled tPA prevents impairment of cerebral vasodilatory responses and tissue injury in pediatric cerebral hypoxia\/ischemia through inhibition of ERK MAPK activation","volume":"29","author":"Armstead","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0380","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1073\/pnas.88.8.3305","article-title":"Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment","volume":"88","author":"Taylor","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0385","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1182\/blood-2005-11-012336","article-title":"Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis","volume":"108","author":"Zaitsev","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0390","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.molimm.2003.10.017","article-title":"ScFv-mediated in vivo targeting of DAF to erythrocytes inhibits lysis by complement","volume":"40","author":"Spitzer","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0395","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1182\/blood-2005-05-2002","article-title":"Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature","volume":"106","author":"Ding","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0400","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.4049\/jimmunol.164.3.1505","article-title":"A soluble recombinant multimeric anti-Rh(D) single-chain Fv\/CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes","volume":"164","author":"Oudin","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0405","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2141.2000.02037.x","article-title":"The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage","volume":"109","author":"Kina","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0410","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.4049\/jimmunol.175.11.7763","article-title":"In vivo correction of complement regulatory protein deficiency with an inhibitor targeting the red blood cell membrane","volume":"175","author":"Spitzer","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0415","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.4049\/jimmunol.177.8.4953","article-title":"Cutting edge: treatment of complement regulatory protein deficiency by retroviral in vivo gene therapy","volume":"177","author":"Spitzer","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0420","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1124\/jpet.109.159194","article-title":"Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis","volume":"332","author":"Zaitsev","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0425","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1182\/blood-2010-01-261610","article-title":"Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation","volume":"115","author":"Zaitsev","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0430","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1182\/blood-2011-12-398149","article-title":"Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis","volume":"119","author":"Zaitsev","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0435","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1139\/O10-154","article-title":"Modelling the structure of the red cell membrane","volume":"89","author":"Burton","year":"2011","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0440","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4049\/jimmunol.158.2.842","article-title":"Bispecific monoclonal antibody complexes bound to primate erythrocyte complement receptor 1 facilitate virus clearance in a monkey model","volume":"158","author":"Taylor","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0445","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2249.2005.02764.x","article-title":"A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1)","volume":"140","author":"Repik","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0450","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/eji.1830240913","article-title":"Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys","volume":"24","author":"Reist","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0455","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.4049\/jimmunol.159.8.4035","article-title":"Bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model","volume":"159","author":"Taylor","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0460","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1021\/mp1001697","article-title":"Improving protein pharmacokinetics by engineering erythrocyte affinity","volume":"7","author":"Kontos","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0465","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s11095-016-1864-x","article-title":"Nanoparticle attachment to erythrocyte via the glycophorin a targeted ERY1 ligand enhances binding without impacting cellular function","volume":"33","author":"Sahoo","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0470","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1182\/blood.V86.1.342.bloodjournal861342","article-title":"Perturbation of red blood cell membrane rigidity by extracellular ligands","volume":"86","author":"Paulitschke","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0475","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1182\/blood-2001-12-0329","article-title":"Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis","volume":"101","author":"Gallagher","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0480","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0485","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1172\/JCI111907","article-title":"Erythrocyte membrane rigidity induced by glycophorin A\u2013ligand interaction. Evidence for a ligand-induced association between glycophorin A and skeletal proteins","volume":"75","author":"Chasis","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0490","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1182\/blood-2010-04-273904","article-title":"Ligation of complement receptor 1 increases erythrocyte membrane deformability","volume":"116","author":"Glodek","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0495","article-title":"Naturally occurring human anti-band 3 autoantibodies accelerate clearance of erythrocytes in guinea pigs","volume":"85","author":"Sticher","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0500","doi-asserted-by":"crossref","first-page":"e0141206","DOI":"10.1371\/journal.pone.0141206","article-title":"Ligation of glycophorin a generates reactive oxygen species leading to decreased red blood cell function","volume":"11","author":"Khoory","year":"2016","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.tmrv.2016.08.004_bb0505","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.thromres.2014.03.017","article-title":"Fibrinogen and red blood cells in venous thrombosis","volume":"133","author":"Aleman","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0510","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1182\/blood.V64.6.1228.1228","article-title":"Red blood cell deformability influences platelets\u2014vessel wall interaction in flowing blood","volume":"64","author":"Aarts","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0515","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2141.2008.07055.x","article-title":"Erythrocyte vesiculation: a self-protective mechanism?","volume":"141","author":"Willekens","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0520","doi-asserted-by":"crossref","first-page":"e104200","DOI":"10.1371\/journal.pone.0104200","article-title":"Erythrocyte-derived microparticles supporting activated protein C\u2013mediated regulation of blood coagulation","volume":"9","author":"Koshiar","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0525","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/ATVBAHA.113.302378","article-title":"Erythrocyte-derived microvesicles amplify systemic inflammation by thrombin-dependent activation of complement","volume":"34","author":"Zecher","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0530","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1182\/blood-2014-07-589283","article-title":"Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease","volume":"125","author":"Camus","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0535","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0037-1614486","article-title":"Contribution of erythrocytes to thrombin generation in whole blood","volume":"81","author":"Peyrou","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0540","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2141.1999.01718.x","article-title":"Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium","volume":"107","author":"Closse","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0545","doi-asserted-by":"crossref","first-page":"20221","DOI":"10.1074\/jbc.M610737200","article-title":"Characterization of heme as activator of toll-like receptor 4","volume":"282","author":"Figueiredo","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0550","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1182\/blood.V74.5.1836.1836","article-title":"Inhibition of malarial parasite invasion by monoclonal antibodies against glycophorin A correlates with reduction in red cell membrane deformability","volume":"74","author":"Pasvol","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0555","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2007.06839.x","article-title":"Modifying the red cell surface: towards an ABO-universal blood supply","volume":"140","author":"Olsson","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0560","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1517\/14740338.2012.678832","article-title":"Immune hemolytic anemia caused by drugs","volume":"11","author":"Garratty","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0565","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1537-2995.2011.03321.x","article-title":"Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia","volume":"52","author":"Arndt","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0570","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1537-2995.2000.40070801.x","article-title":"RBC T activation and hemolysis: implications for pediatric transfusion management","volume":"40","author":"Crookston","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0575","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1365-2141.1995.tb05425.x","article-title":"A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion","volume":"91","author":"Heddle","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0580","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tracli.2012.03.002","article-title":"Effects of genetic, epigenetic, and environmental factors on alloimmunization to transfused antigens: current paradigms and future considerations","volume":"19","author":"Zimring","year":"2012","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0585","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000368995","article-title":"Factors influencing RBC alloimmunization: lessons learned from murine models","volume":"41","author":"Ryder","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0590","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1537-2995.2012.03641.x","article-title":"Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells","volume":"52","author":"Smith","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0595","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1182\/blood-2013-06-508952","article-title":"A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation","volume":"122","author":"Girard-Pierce","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0600","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1537-2995.2012.03910.x","article-title":"Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion","volume":"53","author":"Liepkalns","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0605","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3324\/haematol.2012.065144","article-title":"Partial tolerance of autoreactive B and T cells to erythrocyte-specific self-antigens in mice","volume":"97","author":"Hudson","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0610","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1073\/pnas.1216353110","article-title":"Engineering antigens for in situ erythrocyte binding induces T-cell deletion","volume":"110","author":"Kontos","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0615","doi-asserted-by":"crossref","first-page":"e1500112","DOI":"10.1126\/sciadv.1500112","article-title":"Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase","volume":"1","author":"Lorentz","year":"2015","journal-title":"Sci Adv"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0620","doi-asserted-by":"crossref","first-page":"15907","DOI":"10.1038\/srep15907","article-title":"Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens","volume":"5","author":"Grimm","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0625","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1016\/j.vaccine.2006.05.013","article-title":"The mouse immune response to carrier erythrocyte entrapped antigens","volume":"24","author":"Murray","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0630","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2011-09-382655","article-title":"Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs","volume":"119","author":"Smith","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0635","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/trf.13497","article-title":"Erythrophagocytosis by plasmacytoid dendritic cells and monocytes is enhanced during inflammation","volume":"56","author":"Richards","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0640","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1182\/blood-2010-10-310409","article-title":"Flow-dependent channel formation in clots by an erythrocyte-bound fibrinolytic agent","volume":"117","author":"Gersh","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0645","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1538-7836.2010.03802.x","article-title":"The spatial dynamics of fibrin clot dissolution catalyzed by erythrocyte-bound vs. free fibrinolytics","volume":"8","author":"Gersh","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0650","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fphys.2013.00376","article-title":"Survival of red blood cells after transfusion: processes and consequences","volume":"4","author":"Bosman","year":"2013","journal-title":"Front Physiol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0655","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1537-2995.2008.01734.x","article-title":"Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods","volume":"48","author":"Luten","year":"2008","journal-title":"Transfusion"},{"issue":"Suppl. 2","key":"10.1016\/j.tmrv.2016.08.004_bb0660","first-page":"s7","article-title":"Time to revisit red blood cell additive solutions and storage conditions: a role for \u201comics\u201d analyses","volume":"10","author":"Sparrow","year":"2012","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0665","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cbpa.2010.06.170","article-title":"Antibody-drug conjugates: targeted drug delivery for cancer","volume":"14","author":"Alley","year":"2010","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0670","series-title":"Standards for perioperative autologous blood collection and adminstration, 6th edition","author":"Aabb","year":"2014"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0675","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00384-013-1658-0","article-title":"Technetium-labeled erythrocyte scintigraphy in acute gastrointestinal bleeding","volume":"28","author":"Tabibian","year":"2013","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0680","author":"U.S.F.a.D. Administration"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0685","doi-asserted-by":"crossref","first-page":"10131","DOI":"10.1073\/pnas.1409861111","article-title":"Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes","volume":"111","author":"Shi","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0690","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1182\/blood-2011-06-362038","article-title":"Proof of principle for transfusion of in vitro-generated red blood cells","volume":"118","author":"Giarratana","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0695","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1164\/rccm.201501-0145OC","article-title":"Effects of aged stored autologous red blood cells on human endothelial function","volume":"192","author":"Risbano","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0700","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1537-2995.2011.03096.x","article-title":"Harmful effects of transfusion of older stored red blood cells: iron and inflammation","volume":"51","author":"Hod","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0705","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood-2014-11-567750","article-title":"Established and theoretical factors to consider in assessing the red cell storage lesion","volume":"125","author":"Zimring","year":"2015","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1016\/j.tmrv.2016.08.004_bb0710","first-page":"s12","article-title":"Red blood cell deformability during storage: towards functional proteomics and metabolomics in the Blood Bank","volume":"10","author":"Cluitmans","year":"2012","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0715","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/2012.jama.11953","article-title":"Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial","volume":"308","author":"Fergusson","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0720","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1414219","article-title":"Effects of red-cell storage duration on patients undergoing cardiac surgery","volume":"372","author":"Steiner","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0725","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1001\/jama.2015.13977","article-title":"Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia: the TOTAL randomized clinical trial","volume":"314","author":"Dhabangi","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2016.08.004_bb0730","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1500704","article-title":"Age of transfused blood in critically ill adults","volume":"372","author":"Lacroix","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796316300621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796316300621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T02:13:38Z","timestamp":1749608018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796316300621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0887796316300621"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2016.08.004","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2016.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}